Concomitant infection with Mycobacterium leprae and Mycobacterium tuberculosis in an immunocompetent patient: A rare association Leprosy is a chronic infectious disease caused by Mycobacterium leprae, a microorganism that usually affects skin and nerves. Although it is well-controlled by multidrug therapy but the disease may be aggravated by acute inflammatory reaction that causes permanent tissue damage, particularly to peripheral nerves. Cutaneous tuberculosis (CT) is a variant of extrapulmonary tuberculosis. Both mycobacterial infections are endemic in developing countries like India, but the simultaneous occurrence of CT and leprosy is very rarely reported. Here, we are reporting a case of borderline lepromatous leprosy and CT (lupus vulgaris) co-infection in an immunocompetent patient, diagnosed simultaneously and managed accordingly.
<p>Cutaneous lymphangiectasia of the genitalia represent dilatation of upper dermal lymphatic’s following damage to previously normal deep lymphatics, is an uncommon condition and only few cases have been reported following pulmonary tuberculosis. Here we are describing a case of 75 years old female patient, who came with multiple translucent papulovesicular lesions over the vulva, labia majora, minora and upper thigh from twelve year duration, with watery discharge since eight years. She had a history of pulmonary tuberculosis twenty years ago. The patient underwent punch biopsy of the lesion over the vulva and histopathological examination confirmed our diagnosis as lymphangiectasia of the vulva. She was managed conservatively with anti-tubercular drugs and got relief in watery discharge and skin lesions.</p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.